Medscape

Nearly 10 years after the first JAK inhibitor was approved for a dermatologic disorder, more uses are imminent, with fewer […]

In patients with relapsed or refractory systemic lupus erythematosus, allogeneic CAR-NK cell therapy may offer a safe treatment option and

Patients with indolent systemic mastocytosis exhibit a distinct vertebral fracture pattern, marked by a predominance of biconcave fractures, differentiating it

Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic antibody-associated vasculitis differ according to treatment

‘Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said

A report card on meeting goals of reducing activity and work limitations for people with arthritis delivers bleak news, but

How did some clinicians outside of private practice come to the dueling viewpoints that private practice is “dead” but that

Small-for-gestational-age births are more common among mothers with spondyloarthritis than in the general population; other adverse pregnancy outcomes are comparable.

New indication follows recent approval for idiopathic pulmonary fibrosis. Medscape Medical News

The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

Individuals with type 2 diabetes and painful symptomatic knee osteoarthritis are less likely to achieve target glycemic control. Medscape Medical

A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and quality of life

Among patients with psoriasis who have active or recent cancer, biologic therapies show similar cancer progression or recurrence and serious

COVID booster vaccinations — both monovalent and bivalent — offer benefits in reducing the risk for severe outcomes of COVID

Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate alone, in a trial of

A UK-led systematic review reports high rates of sexual dysfunction in individuals with axial spondyloarthritis, highlighting gaps in routine assessment

Bemotrizinol’s manufacturer said that it expects this ingredient to be available for use in sunscreens in the summer of 2026.

Adding romosozumab to ongoing denosumab treatment shows increased lumbar spine bone mineral density with preserved anabolic effect in postmenopausal women

In children born to mothers with chronic inflammatory diseases, the use of TNF inhibitors during pregnancy is not tied to

Better outcomes may come from new drugs, strategies to rev up the immune system and learning to identify the disease

At a roundtable discussion, speakers aired grievances about what they said was the lack of interest in the condition and

New evidence suggests that the risk for fracture increases within months of low-dose prednisone, challenging the idea of a safe

Transcutaneous auricular vagus nerve stimulation demonstrates safety and potential benefits in patients with erosive hand osteoarthritis but does not reduce

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies.

Jonathan A. Bernstein, MD, discusses the latest advances in diagnosis and treatment of hereditary angioedema, including new therapies, clinical challenges,

The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, efficacy, and cost-effectiveness compared

The majority of knees without radiographic osteoarthritis experience an increase in structural damage over time, with the most frequent changes